Proteonomix Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Proteonomix has 7.91 million shares outstanding.
| Current Share Class | 7.91M |
| Shares Outstanding | 7.91M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48
| Current Ratio | 0.48 |
| Quick Ratio | 0.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.11 |
| Interest Coverage | -51.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -50.99% |
| Return on Invested Capital (ROIC) | -189.54% |
| Return on Capital Employed (ROCE) | 347,942.96% |
| Weighted Average Cost of Capital (WACC) | 2.15% |
| Revenue Per Employee | 13,002 |
| Profits Per Employee | -313,326 |
| Employee Count | 5 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Proteonomix has paid 54 in taxes.
| Income Tax | 54 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -79.92 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 43.36 |
| Average Volume (20 Days) | 52,664 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Proteonomix had revenue of 26,004 and -626,652 in losses. Loss per share was -0.08.
| Revenue | 26,004 |
| Gross Profit | 26,517 |
| Operating Income | -3.78M |
| Pretax Income | -671,997 |
| Net Income | -626,652 |
| EBITDA | -3.41M |
| EBIT | -3.78M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 2.40 million in cash and 2.71 million in debt, with a net cash position of -309,350 or -0.04 per share.
| Cash & Cash Equivalents | 2.40M |
| Total Debt | 2.71M |
| Net Cash | -309,350 |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -1,087 |
| Book Value Per Share | -0.00 |
| Working Capital | -2.97M |
Cash Flow
In the last 12 months, operating cash flow was -1.27 million and capital expenditures -12,635, giving a free cash flow of -1.28 million.
| Operating Cash Flow | -1.27M |
| Capital Expenditures | -12,635 |
| Free Cash Flow | -1.28M |
| FCF Per Share | -0.16 |
Margins
| Gross Margin | 101.97% |
| Operating Margin | -14,544.45% |
| Pretax Margin | -2,584.21% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Proteonomix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.73% |
| Shareholder Yield | -40.73% |
| Earnings Yield | -7,833,150.00% |
| FCF Yield | -16,018,362.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 21, 2008. It was a reverse split with a ratio of 0.1.
| Last Split Date | Aug 21, 2008 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Proteonomix has an Altman Z-Score of -6.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.55 |
| Piotroski F-Score | 2 |